These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36529370)
1. Extended-spectrum β-lactamase- and AmpC β-lactamase-producing Enterobacterales associated with urinary tract infections in the New Zealand community: a case-control study. Toombs-Ruane LJ; Marshall JC; Benschop J; Drinković D; Midwinter AC; Biggs PJ; Grange Z; Baker MG; Douwes J; Roberts MG; French NP; Burgess SA Int J Infect Dis; 2023 Mar; 128():325-334. PubMed ID: 36529370 [TBL] [Abstract][Full Text] [Related]
2. Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households. Toombs-Ruane LJ; Benschop J; French NP; Biggs PJ; Midwinter AC; Marshall JC; Chan M; Drinković D; Fayaz A; Baker MG; Douwes J; Roberts MG; Burgess SA Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 33036993 [TBL] [Abstract][Full Text] [Related]
3. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials. Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490 [TBL] [Abstract][Full Text] [Related]
5. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children. Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka. Perera PDVM; Gamage S; De Silva HSM; Jayatilleke SK; de Silva N; Aydin A; Enne VI; Corea EM J Glob Antimicrob Resist; 2022 Sep; 30():115-122. PubMed ID: 35667644 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country. Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052 [TBL] [Abstract][Full Text] [Related]
10. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study. Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471 [TBL] [Abstract][Full Text] [Related]
11. Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study. Castillo-Tokumori F; Irey-Salgado C; Málaga G Int J Infect Dis; 2017 Feb; 55():16-19. PubMed ID: 27979787 [TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Meier S; Weber R; Zbinden R; Ruef C; Hasse B Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study. Collingwood JD; Wang L; Aban IB; Yarbrough AH; Boppana SB; Dangle PP J Pediatr Urol; 2023 Feb; 19(1):129.e1-129.e7. PubMed ID: 36344365 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616 [No Abstract] [Full Text] [Related]
15. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462 [TBL] [Abstract][Full Text] [Related]
16. International travel increases risk of urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacterales-three-arm case-control study. Patjas A; Martelius A; Ollgren J; Kantele A J Travel Med; 2024 Jan; 31(1):. PubMed ID: 38123504 [TBL] [Abstract][Full Text] [Related]
17. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020. Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203 [TBL] [Abstract][Full Text] [Related]